Quality of life in patients with liver tumors treated with holmium-166 radioembolization

Caren van Roekel, Maarten L J Smits, Jip F Prince, Rutger C G Bruijnen, Maurice A A J van den Bosch, Marnix G E H Lam

Research output: Contribution to journalArticleAcademicpeer-review

3 Downloads (Pure)

Abstract

Holmium-166 radioembolization is a palliative treatment option for patients with unresectable hepatic malignancies. Its influence on quality of life has not been evaluated yet. Since quality of life is very important in the final stages of disease, the aim of this study was to evaluate the effect of holmium-166 radioembolization on quality of life. Patients with hepatic malignancies were treated with holmium-166 radioembolization in the HEPAR I and II studies. The European Organization for Research and Treatment of Cancer QLQ-C30 and LMC21 questionnaires were used to evaluate quality of life at baseline, 1 week, 6 weeks and at 6, 9 and 12 months after treatment. The course of the global health status and symptom and functioning scales were analyzed using a linear mixed model. Quality of life was studied in a total of 53 patients with a compliance of 94%. Role functioning was the most affected functioning scale. Fatigue and pain were the most affected symptom scales. Changes in almost all categories were most notable at 1 week after treatment. A higher WHO performance score at baseline decreased global health status, physical functioning, role functioning and social functioning and it increased symptoms of fatigue, dyspnea and diarrhea. Quality of life in salvage patients with liver metastases treated with holmium-166 radioembolization was not significantly affected over time, although a striking decline was seen during the first week post-treatment. A WHO performance score > 0 at baseline significantly influenced quality of life.

Original languageEnglish
Pages (from-to)95-105
Number of pages11
JournalClinical & Experimental Metastasis
Volume37
Issue number1
Early online date15 Nov 2019
DOIs
Publication statusPublished - 1 Feb 2020

Keywords

  • Hepatic metastases
  • Holmium-166
  • Quality of life
  • Radioembolization

Fingerprint

Dive into the research topics of 'Quality of life in patients with liver tumors treated with holmium-166 radioembolization'. Together they form a unique fingerprint.

Cite this